IPO registrations (S-1, F-1) · Registrants

Autolus Therapeutics plc

SEC CIK

1730463 · filings on EDGAR ↗

Former names

Autolus Therapeutics Ltd (2018–2018)

Registration

Form F-1, S-1, first filed 2018-05-07, last 2025-05-08; 3 initial registrations, 3 amendments

Outcome

Final prospectus filed 2018-06-22; declared effective 2018-06-21

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Incorporated in

X0

Business address

THE MEDIAWORKS, 191 WOOD LANE, London, X0 W12 7FP

Ticker

AUTL (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

Autolus Therapeutics plc on the corporate pages

Offering terms

Proposed price range

$15.00–$17.00 per ADS (F-1/A filed 2018-06-19)

Final price

$17.00 per ADS, within the range (424B4 filed 2018-06-22, an initial public offering)

Shares sold

8,823,530

Gross proceeds

$150,000,010 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol AUTL

Lead underwriters

Goldman Sachs; Jefferies

Syndicate

Wells Fargo; William Blair

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Form D issuer: Autolus Therapeutics plc EXACT (CIK (EXACT))
• SEC filer: Autolus Therapeutics plc EXACT (CIK (EXACT))

Filings 22

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), X0 first:

• Abcam plc X0
• Immunocore Holdings plc X0
• Orchard Therapeutics plc X0
• Freeline Therapeutics Holdings plc X0
• Achilles Therapeutics plc X0
• Gyroscope Therapeutics Holdings plc X0
• OKYO Pharma Ltd X0
• Exscientia plc X0
• TC BioPharm (Holdings) plc X0
• BioNTech SE 2M

More with this interest.

In other datasets, the same topic (Health) in X0:

• Form D issuer: Abcam plc (Form D private offerings)

Interests: Biological Products, (No Diagnostic Substances) · Health